Viewing Study NCT01187303


Ignite Creation Date: 2025-12-24 @ 7:40 PM
Ignite Modification Date: 2025-12-25 @ 5:20 PM
Study NCT ID: NCT01187303
Status: COMPLETED
Last Update Posted: 2015-11-02
First Post: 2010-08-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Ofatumumab in Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL)
Sponsor: University of Cologne
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module